Innovita Biological Technology Co. Ltd. A (688253) — Financial Flexibility Index
Innovita Biological Technology Co. Ltd. A (688253) has a Financial Flexibility Index of 1.00x as of December 2025. Free cash flow of CN¥224.26 Million (operating CF CN¥193.13 Million minus capex CN¥31.13 Million) represents 1% of total liabilities (CN¥223.32 Million). Check 688253 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Innovita Biological Technology Co. Ltd. A Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Innovita Biological Technology Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see Innovita Biological Technology Co. Ltd. (688253) cash conversion ratio.
Annual Financial Flexibility Index for Innovita Biological Technology Co. Ltd. A (2020–2025)
Year-by-year free cash flow to debt coverage for Innovita Biological Technology Co. Ltd. A. Explore Innovita Biological Technology Co. Ltd. (688253) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | CN¥224.26 Million | CN¥193.13 Million | CN¥223.32 Million | ▼ -35.6% |
| 2024 | 1.56x | CN¥341.62 Million | CN¥305.46 Million | CN¥219.07 Million | ▲ +26.0% |
| 2023 | 1.24x | CN¥276.82 Million | CN¥259.85 Million | CN¥223.65 Million | ▲ +70.2% |
| 2022 | 0.73x | CN¥184.14 Million | CN¥126.43 Million | CN¥253.24 Million | ▼ -74.5% |
| 2021 | 2.85x | CN¥170.02 Million | CN¥106.27 Million | CN¥59.70 Million | ▼ -54.7% |
| 2020 | 6.28x | CN¥716.53 Million | CN¥639.82 Million | CN¥114.08 Million | — |